Solazyme (SZYM) Misses Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Cowen Cuts Price Target on Solazyme (SZYM) Following Earnings Results
July 31, 2015 7:56 AM EDTCowen maintained a Market Perform rating on Solazyme (NASDAQ: SZYM), and cut the price target to $3.25 (from $4.00), following its earnings results. Solazyme reported $11.7mn in revenue for the quarter, missing consensus estimates of and $14.3mn. Adjusted EPS was ($0.40) versus consensus estimate of ($0.37).
Analyst... More
